Summary of Study ST003128

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001944. The data can be accessed directly via it's Project DOI: 10.21228/M8FD9G This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST003128
Study TitleEffect of high fat diet on serum fatty acids, lipidome and metabolome in CHCHD10 mutant mice
Study SummaryMutations in CHCHD10, a mitochondrial protein with undefined functions, are associated with autosomal dominant mitochondrial diseases. Chchd10 knock-in mice harboring a heterozygous S55L mutation (equivalent to human pathogenic S59L) develop a fatal mitochondrial cardiomyopathy caused by CHCHD10 aggregation and proteotoxic mitochondrial integrated stress response (mtISR). In mutant hearts, mtISR is accompanied by a metabolic rewiring characterized by increased reliance on glycolysis rather than fatty acid oxidation. To counteract this metabolic rewiring, heterozygous S55L mice were subjected to chronic high fat diet (HFD) to decrease insulin sensitivity and glucose uptake and enhance fatty acid utilization in the heart. HFD ameliorated the ventricular dysfunction of mutant hearts and significantly extended the survival of mutant female mice affected by severe pregnancy-induced cardiomyopathy. Gene expression profiles confirmed that HFD increased fatty acid utilization and ameliorated cardiomyopathy markers. Importantly, HFD also decreased accumulation of aggregated CHCHD10 in the S55L heart, suggesting activation of quality control mechanisms. Overall, our findings indicate that metabolic therapy can be effective in mitochondrial cardiomyopathies associated with proteotoxic stress.
Institute
Weill Cornell Medicine
Last NameSouthwell
First NameNneka
Address407 E 61st St
Emailnns4001@med.cornell.edu
Phone646-962-8172
Submit Date2024-03-06
Raw Data AvailableYes
Raw Data File Type(s)raw(Thermo)
Analysis Type DetailLC-MS
Release Date2024-03-26
Release Version1
Nneka Southwell Nneka Southwell
https://dx.doi.org/10.21228/M8FD9G
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Project:

Project ID:PR001944
Project DOI:doi: 10.21228/M8FD9G
Project Title:High fat diet ameliorates mitochondrial cardiomyopathy in CHCHD10 mutant mice
Project Summary:Mutations in CHCHD10, a mitochondrial protein with undefined functions, are associated with autosomal dominant mitochondrial diseases. Chchd10 knock-in mice harboring a heterozygous S55L mutation (equivalent to human pathogenic S59L) develop a fatal mitochondrial cardiomyopathy caused by CHCHD10 aggregation and proteotoxic mitochondrial integrated stress response (mtISR). In mutant hearts, mtISR is accompanied by a metabolic rewiring characterized by increased reliance on glycolysis rather than fatty acid oxidation. To counteract this metabolic rewiring, heterozygous S55L mice were subjected to chronic high fat diet (HFD) to decrease insulin sensitivity and glucose uptake and enhance fatty acid utilization in the heart. HFD ameliorated the ventricular dysfunction of mutant hearts and significantly extended the survival of mutant female mice affected by severe pregnancy-induced cardiomyopathy. Gene expression profiles confirmed that HFD increased fatty acid utilization and ameliorated cardiomyopathy markers. Importantly, HFD also decreased accumulation of aggregated CHCHD10 in the S55L heart, suggesting activation of quality control mechanisms. Overall, our findings indicate that metabolic therapy can be effective in mitochondrial cardiomyopathies associated with proteotoxic stress.
Institute:Weill Cornell Medicine
Last Name:Southwell
First Name:Nneka
Address:407 E 61st St
Email:nns4001@med.cornell.edu
Phone:646-962-8172

Subject:

Subject ID:SU003245
Subject Type:Mammal
Subject Species:Mus musculus
Taxonomy ID:10090
Species Group:Mammals

Factors:

Subject type: Mammal; Subject species: Mus musculus (Factor headings shown in green)

mb_sample_id local_sample_id Genotype Treatment Age (d) Sex
SA338967SL_HetCD_6CHCHD10 S55L Het Control Diet 250 F
SA338968S_HetCD_2CHCHD10 S55L Het Control Diet 250 F
SA338969SL_HetCD_3CHCHD10 S55L Het Control Diet 250 F
SA338970SP_HetCD_1CHCHD10 S55L Het Control Diet 250 F
SA338971SL_HetCD_5CHCHD10 S55L Het Control Diet 250 F
SA338972SL_HetCD_2CHCHD10 S55L Het Control Diet 250 F
SA338973SL_HetCD_1CHCHD10 S55L Het Control Diet 250 F
SA338974SL_HetCD_4CHCHD10 S55L Het Control Diet 250 F
SA338975SP_HetCD_6CHCHD10 S55L Het Control Diet 250 F
SA338976S_HetCD_1CHCHD10 S55L Het Control Diet 250 F
SA338977S_HetCD_5CHCHD10 S55L Het Control Diet 250 F
SA338978S_HetCD_6CHCHD10 S55L Het Control Diet 250 F
SA338979SP_HetCD_2CHCHD10 S55L Het Control Diet 250 F
SA338980S_HetCD_4CHCHD10 S55L Het Control Diet 250 F
SA338981S_HetCD_3CHCHD10 S55L Het Control Diet 250 F
SA338982SP_HetCD_5CHCHD10 S55L Het Control Diet 250 F
SA338983SP_HetCD_4CHCHD10 S55L Het Control Diet 250 F
SA338984SP_HetCD_3CHCHD10 S55L Het Control Diet 250 F
SA338985SL_HetHFD_2CHCHD10 S55L Het High Fat Diet 250 F
SA338986SL_HetHFD_5CHCHD10 S55L Het High Fat Diet 250 F
SA338987SL_HetHFD_6CHCHD10 S55L Het High Fat Diet 250 F
SA338988SL_HetHFD_4CHCHD10 S55L Het High Fat Diet 250 F
SA338989SL_HetHFD_3CHCHD10 S55L Het High Fat Diet 250 F
SA338990SP_HetHFD_1CHCHD10 S55L Het High Fat Diet 250 F
SA338991SL_HetHFD_1CHCHD10 S55L Het High Fat Diet 250 F
SA338992SP_HetHFD_4CHCHD10 S55L Het High Fat Diet 250 F
SA338993S_HetHFD_3CHCHD10 S55L Het High Fat Diet 250 F
SA338994SP_HetHFD_2CHCHD10 S55L Het High Fat Diet 250 F
SA338995S_HetHFD_4CHCHD10 S55L Het High Fat Diet 250 F
SA338996S_HetHFD_5CHCHD10 S55L Het High Fat Diet 250 F
SA338997S_HetHFD_2CHCHD10 S55L Het High Fat Diet 250 F
SA338998S_HetHFD_1CHCHD10 S55L Het High Fat Diet 250 F
SA338999SP_HetHFD_3CHCHD10 S55L Het High Fat Diet 250 F
SA339000SP_HetHFD_5CHCHD10 S55L Het High Fat Diet 250 F
SA339001SP_HetHFD_6CHCHD10 S55L Het High Fat Diet 250 F
SA339002S_HetHFD_6CHCHD10 S55L Het High Fat Diet 250 F
SA339003SP_WTCD_4WT Control Diet 250 F
SA339004SP_WTCD_1WT Control Diet 250 F
SA339005SP_WTCD_2WT Control Diet 250 F
SA339006SP_WTCD_3WT Control Diet 250 F
SA339007SP_WTCD_5WT Control Diet 250 F
SA339008SP_WTCD_6WT Control Diet 250 F
SA339009SL_WTCD_1WT Control Diet 250 F
SA339010SL_WTCD_2WT Control Diet 250 F
SA339011SL_WTCD_3WT Control Diet 250 F
SA339012S_WTCD_2WT Control Diet 250 F
SA339013S_WTCD_3WT Control Diet 250 F
SA339014S_WTCD_5WT Control Diet 250 F
SA339015S_WTCD_4WT Control Diet 250 F
SA339016S_WTCD_6WT Control Diet 250 F
SA339017SL_WTCD_4WT Control Diet 250 F
SA339018SL_WTCD_5WT Control Diet 250 F
SA339019S_WTCD_1WT Control Diet 250 F
SA339020SL_WTCD_6WT Control Diet 250 F
SA339021SP_WTHFD_6WT High Fat Diet 250 F
SA339022SP_WTHFD_5WT High Fat Diet 250 F
SA339023SP_WTHFD_1WT High Fat Diet 250 F
SA339024SP_WTHFD_3WT High Fat Diet 250 F
SA339025SP_WTHFD_2WT High Fat Diet 250 F
SA339026SP_WTHFD_4WT High Fat Diet 250 F
SA339027S_WTHFD_3WT High Fat Diet 250 F
SA339028SL_WTHFD_2WT High Fat Diet 250 F
SA339029SL_WTHFD_6WT High Fat Diet 250 F
SA339030SL_WTHFD_5WT High Fat Diet 250 F
SA339031SL_WTHFD_4WT High Fat Diet 250 F
SA339032SL_WTHFD_1WT High Fat Diet 250 F
SA339033S_WTHFD_6WT High Fat Diet 250 F
SA339034S_WTHFD_2WT High Fat Diet 250 F
SA339035SL_WTHFD_3WT High Fat Diet 250 F
SA339036S_WTHFD_4WT High Fat Diet 250 F
SA339037S_WTHFD_5WT High Fat Diet 250 F
SA339038S_WTHFD_1WT High Fat Diet 250 F
Showing results 1 to 72 of 72

Collection:

Collection ID:CO003238
Collection Summary:Blood was collected by cheek bleeds into serum separator tubes. Serum was separated after 30 minutes of clotting at room temperature and centrifugation at 2000xg for 15 min.
Sample Type:Blood (serum)

Treatment:

Treatment ID:TR003254
Treatment Summary:CHCHD10 WT and CHCHD10 S55L heterozygous mice were treated with either a control diet (70% Carbohydrate, 20% Protein, 10% Fat) or High Fat Diet (60% Fat, 20% Protein, 20% Carbohydrate).

Sample Preparation:

Sampleprep ID:SP003252
Sampleprep Summary:Untargeted and targeted metabolomics: Serum metabolites were extracted with 80% methanol. The extracts were clarified by centrifugation at 15,000 g for 10 min. The supernatant was collected and dried down using a SpeedVac. For lipidomics analyses: 180 µl of 90% isopropanol was added to 20 µl serum. Samples were vortexed for 2 min, sonicated for 1 min using a probe sonicator and centrifuged at 15,000 g for 10 min. The supernatant was collected and dried down using a SpeedVac. The dried samples were reconstituted using acetonitrile/isopropanol/water 65:30:5 containing stable isotope labeled internal lipid standards (Splash Lipidomix, Avanti Polar Lipids) prior to LC-MS analysis. Free Fatty Acids: Free fatty acids were extracted from serum using 90% methanol (LC/MS grade, Thermo Scientific). The extracts were clarified by centrifugation at 15,000 g for 10 min. The supernatant was collected and dried down using a SpeedVac. The dried sample was reconstituted using 50% methanol prior to LC-MS analysis.

Chromatography:

Chromatography ID:CH003880
Chromatography Summary:Serum targeted and untargeted metabolomics
Methods Filename:Serum_MS_and_Data_Analysis.pdf
Instrument Name:Thermo Vanquish
Column Name:SeQuant ZIC-pHILIC (150 x 2.1mm, 5um)
Column Temperature:35
Flow Gradient:85% to 30% A in 20 min followed by a wash with 30% A and re-equilibration at 85% A
Flow Rate:150 µl/min
Solvent A:100% acetonitrile
Solvent B:100% water; 0.1% ammonium hydroxide; 20 mM ammonium acetate
Chromatography Type:HILIC
  
Chromatography ID:CH003881
Chromatography Summary:Serum free fatty acids
Methods Filename:Serum_MS_and_Data_Analysis.pdf
Instrument Name:Thermo Vanquish
Column Name:Imtakt Cadenza CD-C18 (150 x 2.1 mm, 3um)
Column Temperature:35
Flow Gradient:0–1.5 min, 50% B; 1.5-3 min, 50-90% B; 3-5.5 min, 90-95% B; 5.5-10 min, 95% B, followed by 5 min of re-equilibration
Flow Rate:150 µl/min
Solvent A:100% water; 5 mM ammonium acetate
Solvent B:85% isopropanol/10% acetonitrile/5% water; 5 mM ammonium acetate
Chromatography Type:Reversed phase
  
Chromatography ID:CH003882
Chromatography Summary:Serum lipidomics
Methods Filename:Serum_MS_and_Data_Analysis.pdf
Instrument Name:Thermo Vanquish
Column Name:Imtakt Cadenza CD-C18 (150 x 2.1 mm, 3um)
Column Temperature:35
Flow Gradient:0–1.5 min, 32% B; 1.5-4 min, 32-45% B; 4-5 min, 45-52% B; 5-8 min, 52-58% B; 8-11 min, 58-66% B; 11-14 min, 66-70% B; 14-18 min, 70-75% B; 21-25 min, isocratic 97% B, 25-25.1 min 97-32% B
Flow Rate:200 µl/min
Solvent A:60% acetonitrile/40% water; 10 mM ammonium formate; 0.1% formic acid
Solvent B:90% isopropanol/10% acetonitrile; 10 mM ammonium formate; 0.1% formic acid
Chromatography Type:Reversed phase

Analysis:

Analysis ID:AN005128
Analysis Type:MS
Analysis Protocol File:Serum_MS_and_Data_Analysis.pdf
Chromatography ID:CH003880
Num Factors:4
Num Metabolites:636
Rt Units:No RT data
Results File:ST003128_AN005128_Results.txt
Units:Peak Intensity
  
Analysis ID:AN005129
Analysis Type:MS
Analysis Protocol File:Serum_MS_and_Data_Analysis.pdf
Chromatography ID:CH003881
Num Factors:4
Num Metabolites:40
Units:Peak Intensity
  
Analysis ID:AN005130
Analysis Type:MS
Analysis Protocol File:Serum_MS_and_Data_Analysis.pdf
Chromatography ID:CH003882
Num Factors:4
Num Metabolites:211
Units:Peak Intensity
  logo